ECSP003733A - TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076) - Google Patents
TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076)Info
- Publication number
- ECSP003733A ECSP003733A ECSP003733A ECSP003733A EC SP003733 A ECSP003733 A EC SP003733A EC SP003733 A ECSP003733 A EC SP003733A EC SP003733 A ECSP003733 A EC SP003733A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- sleep disorders
- desloratadina
- alo1076
- case
- Prior art date
Links
- 208000019116 sleep disease Diseases 0.000 title abstract 2
- 201000010105 allergic rhinitis Diseases 0.000 abstract 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract 1
- JAUOIFJMECXRGI-UHFFFAOYSA-N Neoclaritin Chemical compound C=1C(Cl)=CC=C2C=1CCC1=CC=CN=C1C2=C1CCNCC1 JAUOIFJMECXRGI-UHFFFAOYSA-N 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 206010039094 Rhinitis perennial Diseases 0.000 abstract 1
- 208000036284 Rhinitis seasonal Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000009285 allergic inflammation Effects 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000850 decongestant Substances 0.000 abstract 1
- 229960001271 desloratadine Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000022719 perennial allergic rhinitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 abstract 1
- 229960003908 pseudoephedrine Drugs 0.000 abstract 1
- 208000017022 seasonal allergic rhinitis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen composiciones farmacéuticas para el tratamiento y/o prevención de desórdenes del sueño en una persona que sufre de inflamación alérgica y/o congestión del pasaje aéreo superior asociadas con rinitis alérgica, incluyendo rinitis alérgica estacional o rinitis alérgica perenne, que comprenden una cantidad terapéuticamente efectiva de desloratadina, sola o en combinación con otros activos tales como un descongestivo, por ejemplo, pseudoefedrina, y un portador farmacéuticamente aceptablePharmaceutical compositions for the treatment and / or prevention of sleep disorders are described in a person suffering from allergic inflammation and / or upper airway congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis, comprising a therapeutically amount. Effective of desloratadine, alone or in combination with other active ingredients such as a decongestant, for example, pseudoephedrine, and a pharmaceutically acceptable carrier
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003733 ECSP003733A (en) | 2000-10-20 | 2000-10-20 | TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003733 ECSP003733A (en) | 2000-10-20 | 2000-10-20 | TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003733A true ECSP003733A (en) | 2001-05-23 |
Family
ID=42041312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003733 ECSP003733A (en) | 2000-10-20 | 2000-10-20 | TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003733A (en) |
-
2000
- 2000-10-20 EC ECSP003733 patent/ECSP003733A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026181A1 (en) | TREATMENT OF SUENO DISORDERS THROUGH THE USE OF DESLORATADINA | |
| ATE431738T1 (en) | OPIOID AGONIST FORMULATIONS WITH RELEASABLE AND SEQUESTRED ANTAGONIST | |
| CO5011096A1 (en) | MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS | |
| AR008293A1 (en) | COMPOSITION THAT INCLUDES AN ANTIHISTAMINIC AMOUNT FOR THE TREATMENT OF ALLERGIC RESPONSES OF THE SUPERIOR RESPIRATORY TRACT | |
| AR035500A1 (en) | USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE. | |
| CL2008003938A1 (en) | Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00). | |
| DK1257254T3 (en) | Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease | |
| AU3846901A (en) | Oral, nasal and pulmonary dosage formualtions of copolymer 1 | |
| CL2008002407A1 (en) | Oral dosage form comprising at least one nicotine active agent, at least one bioadhesive material capable of forming a hydrogen bond with the nicotine active agent, and at least one rapidly releasing sensory impact agent; and its use to provide rapid relief from nicotine cravings (div. sol. 1825-04). | |
| ATE333896T1 (en) | VASCULARIZATION INHIBITORS | |
| ES2250416T3 (en) | STIMULANT OF SECRECIOHN OF HORMONE OF GROWTH. | |
| AR033179A1 (en) | COMBINATION OF PHARMACOS FOR INHALATION | |
| AR062775A1 (en) | PHARMACEUTICAL COMPOSITION ABLE TO IMPROVE THE ACTIVITY OF LPG -1 IN A HUMAN BEING AND ITS USE TO PREPARE A MEDICINAL PRODUCT | |
| UY27296A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN | |
| BR0317370A (en) | Pharmaceutical composition and palliative method | |
| AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| IL167890A (en) | Use of a chorionic gonadotropin in the preparation of a medicament for treating a chronic pelvic pain syndrome | |
| ECSP003733A (en) | TREATMENT OF SLEEP DISORDERS THROUGH THE USE OF DESLORATADINA (CASE ALO1076) | |
| EE200100689A (en) | Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition | |
| PE20011080A1 (en) | USE OF MIRTAZAPINE FOR THE TREATMENT OF SLEEP DISORDERS | |
| AR031122A1 (en) | USE OF ENDOTHELINE ANTAGONISTS IN THE MANUFACTURE OF USEFUL MEDICINES FOR THE TREATMENT OF CANCER AND PAIN ASSOCIATED WITH THE SAME | |
| SE0000303D0 (en) | Novel compounds | |
| BR0009704A (en) | Use of osanetant for the preparation of drugs useful in the treatment of mood disorders | |
| AR040764A1 (en) | PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE |